AbbVie Inc. (ABBV)
AbbVie Inc. (ABBV)
$66.64 USD
Updated Aug 20 3:53pm
Add ABBV to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
ABBV Stock Chart More Charts
ABBV Price/Volume Stats
| Current price | $66.64 |
| Prev. close | $66.56 |
| Day low | $66.33 |
| Day high | $68.46 |
| 50-day MA | $70.11 |
| 200-day MA | $79.44 |
| 52-week high | $98.70 |
| 52-week low | $62.66 |
| Volume | 10,460,859 |
| Avg. volume | 8,016,649 |
| Dividend yield | 6.43% |
| Market Cap | 98.53B |
AbbVie Inc. (ABBV) Company Bio
Abbvie develops and markets therapies that address a range of diseases. The Company's products are focused on treating conditions, such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis and Crohn's disease, hepatitis C, human immunodeficiency virus, endometriosis, thyroid disease, Parkinson's disease, complications associated with chronic kidney disease and cystic fibrosis, and other health conditions, such as low testosterone. The company was founded in 2012 and is based in North Chicago, Illinois.
Loading social stream, please wait...